Genomics is a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools and bring new understanding to drug discovery. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford. Genomics is collaborating with some of the world’s leading healthcare organizations and helping them to predict, prevent, treat, and cure—dramatically reducing the human and financial cost of common diseases like cancer, diabetes, and heart disease.

Foresite Capital believes that Genomics plc will accelerate drug discovery for patients in the UK and around the world.